These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21362749

  • 1. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
    Pan HF, Leng RX, Tao JH, Li XP, Ye DQ.
    Lupus; 2011 Mar; 20(3):227-30. PubMed ID: 21362749
    [Abstract] [Full Text] [Related]

  • 2. The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus.
    Leng RX, Pan HF, Chen GM, Feng CC, Fan YG, Ye DQ, Li XP.
    Autoimmun Rev; 2011 Jun; 10(8):439-43. PubMed ID: 21296190
    [Abstract] [Full Text] [Related]

  • 3. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus?
    Gilbert D, Brard F, Jovelin F, Tron F.
    J Autoimmun; 1996 Apr; 9(2):247-57. PubMed ID: 8738970
    [Abstract] [Full Text] [Related]

  • 4. [Role of transcription factor ETS-1 and B cell in the pathogenesis of systemic lupus erythematosus].
    Ren QJ, Li XP, Tao JH, Yu N, Li XM, Wang GS, Zhang H, Fang X.
    Zhonghua Yi Xue Za Zhi; 2013 Aug 20; 93(31):2483-6. PubMed ID: 24300270
    [Abstract] [Full Text] [Related]

  • 5. The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development.
    Savino MT, Ulivieri C, Emmi G, Prisco D, De Falco G, Ortensi B, Beccastrini E, Emmi L, Pelicci G, D'Elios MM, Baldari CT.
    J Leukoc Biol; 2013 Apr 20; 93(4):549-59. PubMed ID: 23345394
    [Abstract] [Full Text] [Related]

  • 6. The association between systemic lupus erythematosus and deficiencies of the complement system.
    Goerg S.
    Cell Mol Biol (Noisy-le-grand); 2002 May 20; 48(3):237-45. PubMed ID: 12030427
    [Abstract] [Full Text] [Related]

  • 7. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
    Hostmann A, Jacobi AM, Mei H, Hiepe F, Dörner T.
    Lupus; 2008 Dec 20; 17(12):1064-9. PubMed ID: 19029273
    [Abstract] [Full Text] [Related]

  • 8. Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway.
    Wen Z, Xu L, Chen X, Xu W, Yin Z, Gao X, Xiong S.
    J Immunol; 2013 Jun 01; 190(11):5411-22. PubMed ID: 23616573
    [Abstract] [Full Text] [Related]

  • 9. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan 01; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 10. The immunological basis of B-cell therapy in systemic lupus erythematosus.
    Mok MY.
    Int J Rheum Dis; 2010 Feb 01; 13(1):3-11. PubMed ID: 20374380
    [Abstract] [Full Text] [Related]

  • 11. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
    Bories JC, Willerford DM, Grévin D, Davidson L, Camus A, Martin P, Stéhelin D, Alt FW.
    Nature; 1995 Oct 19; 377(6550):635-8. PubMed ID: 7566176
    [Abstract] [Full Text] [Related]

  • 12. [B-cell anomalies in systemic lupus erythematosus].
    Tron F, Jacquot S, Gilbert D.
    Ann Med Interne (Paris); 2002 Dec 19; 153(8):503-12. PubMed ID: 12610424
    [Abstract] [Full Text] [Related]

  • 13. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
    Reininger L, Santiago ML, Takahashi S, Fossati L, Izui S.
    Ann Med Interne (Paris); 1996 Dec 19; 147(7):467-71. PubMed ID: 9092356
    [Abstract] [Full Text] [Related]

  • 14. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
    Schmidt M, Schmidt AM, Dietl J, Kammerer U.
    Oncol Rep; 2007 Aug 19; 18(2):457-63. PubMed ID: 17611671
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb 19; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 16. The potential role of Ets-1 and miR-326 in CD19+B cells in the pathogenesis of patients with systemic lupus erythematosus.
    Jin L, Fang X, Dai C, Xiang N, Tao J, Sun X, Azmi F, Cao Q, Li X, Wang Y, Li X.
    Clin Rheumatol; 2019 Apr 19; 38(4):1031-1038. PubMed ID: 30456527
    [Abstract] [Full Text] [Related]

  • 17. The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus.
    Kim CJ, Lee CG, Jung JY, Ghosh A, Hasan SN, Hwang SM, Kang H, Lee C, Kim GC, Rudra D, Suh CH, Im SH.
    Immunity; 2018 Dec 18; 49(6):1034-1048.e8. PubMed ID: 30566881
    [Abstract] [Full Text] [Related]

  • 18. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P.
    J Immunol; 2009 Nov 15; 183(10):6207-16. PubMed ID: 19841185
    [Abstract] [Full Text] [Related]

  • 19. Chimerism in systemic lupus erythematosus--three hypotheses.
    Kremer Hovinga IC, Koopmans M, de Heer E, Bruijn JA, Bajema IM.
    Rheumatology (Oxford); 2007 Feb 15; 46(2):200-8. PubMed ID: 17135226
    [Abstract] [Full Text] [Related]

  • 20. Immunogenetic studies on systemic lupus erythematosus.
    Sebastiani GD, Galeazzi M.
    Lupus; 2009 Sep 15; 18(10):878-83. PubMed ID: 19671786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.